September 3, 2026 Advancing Neuromuscular Drug Development Through Patient-Centered Collaboration and Data Integration The newest episode of the Critical Path Institute Podcast explores the essential collaboration between patients...
August 24, 2026 Building a Stronger Path to Therapies for Hereditary Spastic Paraplegia and Primary Lateral Sclerosis For more than 20 years, the Spastic Paraplegia Foundation (SPF) has worked toward a future with better...
August 20, 2026 C-Path CEO Klaus Romero Talks One to Millions on The BioCentury Show Critical Path Institute’s One to Millions Initiative is using individualized rare disease therapies...
July 31, 2026 The Critical Path Institute Podcast: How C-Path’s Accelerator Is Impacting Tomorrow’s Medicines This episode of the Critical Path Institute podcast features Maaike Everts, Executive Director of C-Path’s Translational The
July 29, 2026 Scaling the Science: The Maturation of NAMs and the Demand for Validated Scaling The commercial and regulatory reality of New Approach Methodologies (NAMs) materialized rapidly this conference season.
July 20, 2026 Pamela Dasher Lopez Expected Interesting Courses from the University of Arizona Regulatory Science Certificate. She Came Away Understanding Drug Development More Deeply Than She Expected To. "We all know what happened in March 2020," Pamela Dasher Lopez stated. She was in Sydney then...
July 14, 2026 Karen Bernstein, One of Biotech’s Most Influential Voices, Elected C-Path Board Chair TUCSON, Ariz., July 14, 2026 — Critical Path Institute® (C-Path) today announced that its Board of Directors has elected...
July 3, 2026 Many Conferences Lack Clear Information about Disability Access The logistics and structural barriers of many research conferences prevent full participation of people with disabilities.
July 29, 2026 eCOA Consortium and PCE Consortium Webinar Recording: Event Driven eDiaries At C-Path’s 2026 Clinical Outcome Assessment Program Annual Meeting, attendees heard a brief overview of...
July 9, 2026 Wendy Ruyle Learned That Groundbreaking Science Alone Is Not Enough Early in her career, Wendy Ruyle worked as a study coordinator on clinical trials, a role that put her in direct contact with...
